Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00290_DB01656_nanopub.RAix82EwrD1jk94ahfYUN88MPepg_ysEKJZEI7Qgi0unY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00290_DB01656 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00290_DB01656 label "DDI between Bleomycin and Roflumilast - Roflumilast may enhance the immunosuppressive effect of Immunosuppressants.The Canadian product monograph (Daxas brand) recommends avoiding concurrent use with immunosuppressants. U.S. prescribing information (Daliresp brand) does not include such a warning. [drugbank_resource:DB00290_DB01656]" assertion.
- drugbank_resource:DB00290_DB01656 identifier "drugbank_resource:DB00290_DB01656" assertion.
- drugbank_resource:DB00290_DB01656 title "DDI between Bleomycin and Roflumilast - Roflumilast may enhance the immunosuppressive effect of Immunosuppressants.The Canadian product monograph (Daxas brand) recommends avoiding concurrent use with immunosuppressants. U.S. prescribing information (Daliresp brand) does not include such a warning." assertion.
- drugbank:DB01656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00290_DB01656 assertion.
- drugbank:DB00290 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00290_DB01656 assertion.